WHITEPAPER – Key Considerations in Oral Delivery of Peptides – Factors to Consider While Evaluating Oral Administration

Peptide therapeutics are a hot topic in pharmaceutical R&D. While most peptides are administered parenterally, oral delivery of peptide therapeutics offers several advantages. Enteris BioPharma’s latest whitepaper outlines the key parameters that drug developers should considering while evaluating oral delivery of peptides. Click here to download/view the whitepaper.